Could a triple chemo cocktail beat standard care for tough rectal cancers?
Disease control
Not yet recruiting
This study compares two chemotherapy approaches for people with high-risk locally advanced rectal cancer. One group gets a stronger three-drug combo (FOLFOXIRI) before chemoradiation, while the other gets a standard two-drug combo (CAPOX/FOLFOX). The goal is to see if the stronge…
Phase: PHASE3 • Sponsor: J. W. A. Burger • Aim: Disease control
Last updated May 08, 2026 12:02 UTC